Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis

High-dose methotrexate (HD-MTX) is a potent chemotherapeutic agent used to treat pediatric acute lymphoblastic leukemia (ALL). HD-MTX is known for cause delayed elimination and drug-related adverse events. The...

Source: BMC Medical Informatics and Decision Making - August 3, 2023 Category: Information Technology Authors: Chang Jian, Siqi Chen, Zhuangcheng Wang, Yang Zhou, Yang Zhang, Ziyu Li, Jie Jian, Tingting Wang, Tianyu Xiang, Xiao Wang, Yuntao Jia, Huilai Wang and Jun Gong Tags: Research Source Type: research